The Global Bioinformatics Market Size is valued at USD 13.94 billion in 2023 and is predicted to reach USD 39.79 billion by the year 2031 at a 14.50% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- The integration of artificial intelligence (A.I.) and machine learning (ML) techniques into bioinformatics tools holds immense potential.
- The increasing affordability and accessibility of next-generation sequencing technologies have generated massive amounts of genomic data. Bioinformatics tools are essential for the efficient analysis and interpretation of this data, driving demand in the market.
- North America dominated the market and accounted for a revenue share of global revenue in 2023.
- The handling of sensitive biological and genomic data raises significant concerns about privacy and security.
The management and analysis of biological information using computer technology are known as bioinformatics. It involves collecting, analyzing, and sharing biological data. The field of bioinformatics uses computer algorithms to discover biological linkages, ascertain the roles of genes and proteins, and forecast the three-dimensional structures of proteins.
However, high prices for bioinformatics software and services and a shortage of experienced workers are projected to impede the bioinformatics market growth. The emergence of numerous next-generation data sets that aim to address long-standing problems regarding the biology of human diseases has intensified the current hype surrounding big data analytics' mostly untapped promise. Attempts to harness the potential of big data currently need to be improved by some important obstacles, despite the likelihood that these techniques will effectively reveal fresh biological insights.
The need for bioinformatics is rising in the global market due to rising demand for protein sequencing and nucleic acids and initiatives from public and commercial entities. The market is also fueled by a surge in molecular biology and drug delivery research, as well as the fields of genomics and proteomics. The movement of precision medicine from disorder and reductionist treatment to system-based, holistic, and beings' treatment has been made possible by advances in systems biology and pharmacogenomics.
Common challenges include the efficient evaluation of analytical software tools, the acceleration of the overall process using hybrid parallel computing (HPC) parallelization and kinetic energy technology, the development of automation strategies, data storage alternatives, and, finally, the creation of novel techniques for the full utilization of results across various experimental conditions.
- In November 2023, Users who access the Seven Bridges Platform through Single Sign-On (SSO) can now perform Single (IdP Initiated) logout to log out of multiple SSO sessions in a single click. Also, it is now possible to initiate Global (SP-initiatedS.P.) logout flow from the Seven Bridges Platform.
- In June 2022, LatchBio, a biotechnology research startup in California, debuted an end-to-end bioinformatics platform to handle large amounts of biotech data and speed up scientific research.
Some of the major Bioinformatics market players are:
- Agilent Technologies, Inc.
- Biomax Informatics Ag
- Dnanexus, Inc
- Eurofins Scientific
- Fios Genomics
- Genedata Ag
- Illumina Inc.
- Intrexon Bioinformatics Germany Gmbh
- NeoGenomics Laboratories
- PerkinElmer Inc.
- QIAGEN N.V.
- Seven Bridges Genomics Inc.
- Thermo Fisher Scientific Inc.
- Waters Corporation
The bioinformatics market is segmented based on technology & services, applications and sectors. Based on technology & services, the market is segmented as knowledge management tools (generalized knowledge management tools and specialized knowledge management tools), bioinformatics platforms (sequence analysis platforms, sequence alignment platforms, sequence manipulation platforms, structural analysis platforms and others), services (sequencing services, database management, data analysis and others) By applications, the market is segmented into metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatic & drug design, genomics and others. By sectors, the market is segmented into medical bioinformatics, animal bioinformatics, agriculture bioinformatics, academics and others.
Based On Technology & Services, The Platforms Segment Is A Major Contributor To The Bioinformatics Market
The platforms category is expected to hold a major share of the global bioinformatics Industry in 2022. because more platform applications are being made, drug development requires improved tools. A surge in demand from life science companies for structural health monitoring and modification may be to blame for the increase, in addition to potential. In turn, this would support the development of new drugs and the assessment of their therapeutic effects. Better drug development tools must also be created to boost the speed and safety of drug discovery and development. The increasing use of diverse tools for database administration is fueling the development of bioinformatics platforms. The extensive use of next-generation sequencing also aids the development of bioinformatics platforms. The segment is expanding due to the rising demand for exome and genome technologies.
The Proteomics Segment Witnessed Growth At A Rapid Rate
The proteomics segment is projected to grow at a rapid rate in the global bioinformatics market. Big data analytics' unrealized potential is a feed buzz that has the expansion of R&D initiatives and significant financial investments in technology development credited with driving the proteomics market. These tools aid in the large-scale management and analysis of data. Moreover, algorithms are employed in database management and data monitoring. All these causes are driving the growth of the proteomics market.
The North American Bioinformatics Market Holds A Significant Regional Revenue Share
The North American bioinformatics market is expected to register the highest market share in revenue soon. The North American bioinformatics market position is expanding due to government policies beneficial to market participants and the increasing adoption of trying-to-cut technologies. The American government is still investing in the bioinformatics industry's growth. Also, expanding R&D activities creates opportunities for regional bioinformatics market development. In addition, Asia Pacific egis projected to grow in the global Bioinformatics market demand. The need for more advanced bioinformatics tools, which are essential for medication study and development, as well as a rise in the use of cutting-edge technology, are both to blame for this because of developments in the fields of genomics and proteomics, which produce vast amounts of data that need to be processed and interpreted.
Bioinformatics Market Report Scope
Market size value in 2023
USD 13.94 Bn
Revenue forecast in 2031
USD 39.79 Bn
Growth rate CAGR
CAGR of 14.50% from 2024 to 2031
Representation of revenue in US$ Million, and CAGR from 2024 to 2031
2019 to 2023
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends
Technology & Services, Applications And Sectors
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia
Agilent Technologies, Inc., Biomax Informatics Ag, Dnanexus, Inc., Genedata Ag, Intrexon Bioinformatics Germany Gmbh, Illumina, Inc., Perkinelmer, Inc., Qiagen N.V., Seven Bridges Genomics Inc., Thermo Fisher Scientific, Inc.
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing and available payment methods
Explore pricing alternatives that are customized to your particular study requirements.